Skip to main content

Table 3 SOD and MDA comparison between healthy controls, monotherapy and poly-therapy groups

From: Malondialdehyde and superoxide dismutase levels in patients with epilepsy: a case–control study

  Monotherapy patients (n = 27) Polytherapy patients (n = 35) Healthy controls group (n = 62) ANOVA (F value) p
MDA (nmol/ml)
 Mean ± SD 5.39 ± 1.38¥ 6.16 ± 1.46¥, § 4.8 ± 0.62 17.299 < 0.001*
SOD (U/ml)
 Mean ± SD 7.86 ± 1.01¥ 7.39 ± 0.64¥, § 11.98 ± 1.39 229.121 < 0.001*
  1. MDA malondialdhyde, SOD superoxide dismutase, SD standard deviation, * significant
  2. ¥Significantly (higher MDA and lower SOD) than healthy controls (Tukey Post Hoc Test)
  3. §Significantly (higher MDA and lower SOD) than monotherapy group (Tukey Post Hoc Test)